COVID & other Diseases

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a pandemic by the World Health Organization on March 11, 2020. The rapid global ...

Read our latest blog to learn about the latest biosafety level recommendations from the CDC concerning the SARS-CoV-2 virus.

Finding drugs that treat the COVID-19 coronavirus may be just as important as developing a vaccine. But it's much harder to create effective antivirals than antibiotics.

Biocides are heavily used in the healthcare environment, mainly for the disinfection of surfaces, water, equipment, and antisepsis, but also for the sterilization of medical devices and preservation of pharmaceutical and medicinal products. The number ...

Biodefense and Emerging Infections Research Resources Repository (BEI Resources) is the leading source for reagents, tools and information for studying NIAID's Category A, B, and C priority pathogens and emerging infectious disease agents.

(2020) "we focused on the effects of alcohols, povidone iodine, quaternary ammonium compounds, hydrogen peroxide, sodium hypochlorite (NaOCl), peroxyacetic acid (PAA), chlorine dioxide, ozone, ultraviolet light, metals, and plant-based antimicrobials. This review highlights the differences in the resistance or susceptibility of different strains of coronaviruses, or similar viruses, to these antimicrobial agents."

Approaches for Preventing Healthcare-Associated Infections: Go Long or Go Wide? - Volume 35 Issue 7 - Edward Septimus, Robert A. Weinstein, Trish M. Perl, Donald A. Goldmann, Deborah S. Yokoe

I'm going to take you through some of my thought process when I see a debate. I like to use knowledge and information to resolve debates, but that's not the only way to resolve a debate... there are...

India's confirmed cases are going up rapidly, but it's not all bad news.

Get the facts on what can help to minimise your risk of infection - and the things that probably won’t. Plus we explain the symptoms and what to do if you think you’re affected.

The HPN editorial team is dedicated to ongoing news reporting of COVID-19. Check back daily for the latest stories and subscribe to our daily newsletter.

Researchers behind the non-peer-reviewed paper ran antibody tests on samples from hospital workers who were exposed to patients at early stage of outbreak – only 4 per cent had them, but at least 25 per cent could have been infected.

Spain's large-scale study on the coronavirus indicates just 5% of its population has developed antibodies, strengthening evidence that a so-called herd immunity to Covid-19 is "unachievable," the medical journal the Lancet reported on Monday.

An infectious disease expert says he caught the coronavirus through his eyes on a flight to New Orleans that was “packed in like sardines,” according to a report Thursday. Dr. Joseph Fair — a virol…

Resources and interim guidelines for laboratory professionals working with specimens from persons with coronavirus disease 2019 (COVID-19).

A high prevalence of particles makes patients more infectious, but it is unclear if it leads to a more severe infection.

To evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first four months of the epidemic in Zhejiang province, China.Retrospective cohort ...

Recognizing viral dose may lead to less and less severe infections.

A mathematical analysis of patterns for the evolution of COVID-19 cases is key to the development of reliable and robust predictive models potentially leading to efficient and effective governance against COVID-19. Towards this objective, we study and analyze the temporal growth pattern of COVID-19 infection and death counts in various states of India. Our analysis up to June 16, 2020 shows that several states (namely Maharashtra, Tamil Nadu, Delhi, Uttar Pradesh) have reached t-squared power-law growth, while some others like Gujarat, Rajasthan, and Madhya Pradesh have reached linear growt...

Background. The rising COVID-19 pandemic caused many governments to impose policies restricting social interactions. These policies have slowed down the spread of the SARS-CoV-2 virus to the extent that restric- tions can be gradually lifted. Models can be useful to assess the consequences of deconfinement strategies with respect to business, school and leisure activities. Methods. We adapted the individual-based model "STRIDE" to simulate interactions between the 11 million inhabitants of Belgium at the levels of households, workplaces, schools and communities. We calibrated our model to o...

Surface contamination and fleeting encounters are less of a worry than close-up, person-to-person interactions for extended periods. The emerging scientific findings are helping businesses and governments devise reopening strategies that limit the coronavirus’s spread.

Good Chemistry Lives Here. Learn how antimicrobials are incredibly important for the protection of public health.

Healthcare

Coronavirus disease 2019 (COVID-19) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.